Skip to main content

Your search for “Heart Disease” returned 497 results

Training Clinical Engineers

February 4, 2019

UC San Diego’s Clinical Bioengineering course offers undergraduate engineering students hands-on learning experience to solve clinical problems. The course reflects the Institute of Engineering in Medicine’s mission to connect engineers with physicians to produce medical innovations.

Artificial Blood Vessel Lets Researchers Better Assess Clot Removal Devices

April 17, 2015

Researchers at the University of California, San Diego School of Medicine have created an in vitro, live-cell artificial vessel that can be used to study both the application and effects of devices used to extract life-threatening blood clots in the brain. The artificial vessel could have significant implications for future…

New Skin Patch Brings Us Closer to Wearable, All-In-One Health Monitor

February 15, 2021

UC San Diego engineers have developed a soft, stretchy skin patch that can be worn on the neck to continuously track blood pressure and heart rate while measuring the wearer’s levels of glucose as well as lactate, alcohol or caffeine. It performs as well as several commercial devices in one.

Alexander Khalessi, MD, Named Chair of Neurosurgery Department at UC San Diego Health

January 24, 2018

After a national search, Alexander Khalessi, MD, has been named chair of the Department of Neurosurgery at UC San Diego Health and chief of the Division of Neurosurgery in the Department of Surgery at University of California San Diego School of Medicine.

UC San Diego Health Named National Leader in Delivering High-Quality Patient Care

September 22, 2023

UC San Diego Health is recognized by Vizient as 2023 Birnbaum Quality Leadership Top Performer for the fifth consecutive year.

The Connection Between Oxygen and Diabetes

June 5, 2014

Researchers at the University of California, San Diego School of Medicine have, for the first time, described the sequence of early cellular responses to a high-fat diet, one that can result in obesity-induced insulin resistance and diabetes. The findings also suggest potential molecular targets for preventing or reversing the process.

A Government in COVID-19 Denial

March 25, 2021

…earlier to study Chagas disease, a parasitic infection that is the leading cause of heart disease in South America. “I thought something needed to be done,” McKerrow said. In June 2020, Huete-Pérez and McKerrow began collaborating to collect and analyze data on the rates of COVID-19 infection among Nicaraguan health…

Scientists Discover a Destructive Mechanism That Blocks the Brain from Knowing When to Stop Eating

August 22, 2018

An international team of researchers has uncovered a destructive mechanism at the molecular level that causes a well-known phenomenon associated with obesity, called leptin resistance. They found that mice fed a high-fat diet produce an enzyme named MMP-2 that clips receptors for the hormone leptin from the surface of neuronal…

Paper Calls for Patient-First Regulation of AI in Healthcare

January 31, 2024

A new paper in JAMA describes how, despite widespread enthusiasm about AI’s potential to revolutionize healthcare and the use of AI-powered tools on millions of patients already, no federal regulations require that AI-powered tools be evaluated for potential harm or benefit to patients.

How Resident Microbes Restructure Body Chemistry

February 26, 2020

A comparison of normal and germ-free mice revealed that as much as 70 percent of a mouse’s gut chemistry is determined by its gut microbiome. Even in distant organs, such as the uterus or the brain, approximately 20 percent of molecules were different in the mice with gut microbes.

Category navigation with Social links